Nutrition & DietMost FDA-Approved Chemo Drugs Never Proven to Extend Life or Improve Quality of Life
A review of FDA drug approval practices reveals that most chemotherapy drugs reach the market without solid evidence they extend survival or improve quality of life. Approvals increasingly rely on surrogate endpoints like tumor shrinkage rather than actual patient outcomes. A comprehensive analysis found 91% of validation trials showed little correlation between surrogate endpoints and overall survival. Of 36 chemo drugs approved this way, only one in seven was later confirmed to extend life, half explicitly failed to do so, and the rest remain untested. Meanwhile, costs can reach nearly $1,000 per day, creating devastating financial burdens alongside uncertain medical benefits. Critics argue the FDA should demand proof of meaningful clinical benefit before approval.
